The Latest Breaking News from Pfizer

Five years after Donald Trump declared a national COVID-19 emergency, here's what the research says.

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common.

Upcoming clinical trial results will give investors a much better look into Pfizer’s operational health.

Football legend Joe Montana joins SI's Claudette Montana, on behalf of Pfizer, to discuss Brock Purdy's future in San Francisco, Marcus Freeman and Notre Dame,

Pfizer's Super Bowl ad received mixed reactions on social media, but many criticized the pharma giant for saying it will "knock out" cancer amid concerns over its COVID-19 vaccine.

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they try to do’

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.